This test aims to verify that the management process of renal anemia in maintenance hemodialysis patients can improve the hemoglobin compliance rate better than that of anemia management by primary doctors, and promote the system at the grassroots level to guide primary doctors in anemia management and improve the management standard of renal anemia in maintenance hemodialysis patients through prospective randomized controlled trials. To improve the anemia compliance rate of maintenance hemodialysis patients, and to improve the basic doctors' grasp of the anemia management guidelines, consensus and standard operating procedures.
None
Patients who have planned to undergo kidney transplantation or terminate hemodialysis during the study period; ② Previous history of bone marrow hematopoietic system diseases, such as combined myelodysplastic syndrome, multiple myeloma, and other diseases; ③ Any known hereditary blood disease, such as thalassemia, sickle cell anemia, pure red blood cell aplasia, etc.; ④ Active or chronic gastrointestinal bleeding; ⑤ There was a severe infection within one week prior to screening.
Parallel
Guiding treatment
Other interventionStandardized guidance for anemia treatment by grassroots doctors using the maintenance hemodialysis renal anemia management process
empirical therapy
Other interventionExperiential treatment by grassroots doctors
Changes in the one-year compliance rate of renal anemia
Changes in renal anemia compliance rates between the experimental group and the control group within one year
Click on the lead sponsor to view all of their trials.
Hong Daqing
Lead sponsor
Sichuan Provincial People's Hospital
Sponsor institution
